June 12, 2013
Bioniche Founder and CEO Addresses Shareholders

June 5, 2013
Paladin Labs Inc. and Bioniche Life Sciences Inc. Sign Debt Refinancing and Urocidin™ Licensing Deals

Latest TSX stock price

All prices delayed at least 15 minutes.
Source: TSX Inc.

Latest ASX stock price

All prices delayed at least 20 minutes.
Source: ASX Inc.

• January 10, 2013 – 5:00 p.m. EST

  Urocidin™ Rights Transfer Conference Call and Audio Webcast

  The webcast will be available for replay at

  http://event.on24.com/r.htm? e=557538&s=1&k=36DDCFD341222A4FB29F3FCC7EBEB8C3

  until January 10, 2014.

• February 11, 2013 – 5:00 p.m. EST

  Q2, Fiscal 2013 (Half-Year) Conference Call and Audio Webcast

  The webcast will be available for replay at:

  http://event.on24.com/r.htm? e=565698&s=1&k=FC5CA7D17AD739E05E3C798EDD7E10ED

  until February 11, 2014.

• May 8, 2013 – 5:00 p.m. EST

  Q3, Fiscal 2013 Financials News Release